Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema ; volume:13 ; number:12 ; day:25 ; month:10 ; year:2024 ; pages:3149-3159 ; date:12.2024
Ophthalmology and therapy ; 13, Heft 12 (25.10.2024), 3149-3159, 12.2024
- Creator
-
Chang, Hsin-Ho
Chi, Sheng-Chu
Chen, Shih-Jen
Chou, Yu-Bai
Lin, Tai-Chi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-024-01057-z
- URN
-
urn:nbn:de:101:1-2502040932181.203517920817
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chang, Hsin-Ho
- Chi, Sheng-Chu
- Chen, Shih-Jen
- Chou, Yu-Bai
- Lin, Tai-Chi
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema
Changes in optical coherence tomography biomarkers in eyes with advanced idiopathic epiretinal membrane treated with dexamethasone implantation
Epiretinal Membrane in Patients with Diabetic Macular Edema
OCT biomarkers as predictors of visual improvement in diabetic macular edema eyes receiving dexamethasone implants
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Predictive factors for postoperative visual function in eyes with epiretinal membrane
Increased risk of postsurgical macular edema in high stage idiopathic epiretinal membranes
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema
Epiretinal membrane surgery outcome in eyes with abnormalities of the central bouquet
Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema
Changes in optical coherence tomography biomarkers in eyes with advanced idiopathic epiretinal membrane treated with dexamethasone implantation
Epiretinal Membrane in Patients with Diabetic Macular Edema
OCT biomarkers as predictors of visual improvement in diabetic macular edema eyes receiving dexamethasone implants
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Predictive factors for postoperative visual function in eyes with epiretinal membrane
Increased risk of postsurgical macular edema in high stage idiopathic epiretinal membranes
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema
Epiretinal membrane surgery outcome in eyes with abnormalities of the central bouquet
Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edema
Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema
Changes in optical coherence tomography biomarkers in eyes with advanced idiopathic epiretinal membrane treated with dexamethasone implantation
Epiretinal Membrane in Patients with Diabetic Macular Edema
OCT biomarkers as predictors of visual improvement in diabetic macular edema eyes receiving dexamethasone implants
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Predictive factors for postoperative visual function in eyes with epiretinal membrane
Increased risk of postsurgical macular edema in high stage idiopathic epiretinal membranes
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema